X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse WYETH LTD with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs ACTAVIS (US) - Comparison Results

WYETH LTD    Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 WYETH LTD   ACTAVIS
EQUITY SHARE DATA
    WYETH LTD
Mar-13
ACTAVIS
Dec-14
WYETH LTD/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs1,04418,987-   
Low Rs81811,581-   
Sales per share (Unadj.) Rs298.63,419.0-  
Earnings per share (Unadj.) Rs57.2-426.7-  
Cash flow per share (Unadj.) Rs58.4313.7-  
Dividends per share (Unadj.) Rs17.000-  
Dividend yield (eoy) %1.80-  
Book value per share (Unadj.) Rs249.57,415.7-  
Shares outstanding (eoy) m22.72265.90-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.14.5 69.8%   
Avg P/E ratio x16.3-35.8 -45.4%  
P/CF ratio (eoy) x15.948.7 32.7%  
Price / Book Value ratio x3.72.1 181.1%  
Dividend payout %29.70-   
Avg Mkt Cap Rs m21,1574,064,058 0.5%   
No. of employees `0000.521.6 2.3%   
Total wages/salary Rs m4000-   
Avg. sales/employee Rs Th13,787.442,088.7 32.8%   
Avg. wages/employee Rs Th813.00-   
Avg. net profit/employee Rs Th2,643.3-5,252.2 -50.3%   
INCOME DATA
Net Sales Rs m6,783909,115 0.7%  
Other income Rs m353-2,269 -15.5%   
Total revenues Rs m7,136906,846 0.8%   
Gross profit Rs m1,617116,789 1.4%  
Depreciation Rs m27196,857 0.0%   
Interest Rs m628,675 0.0%   
Profit before tax Rs m1,938-111,012 -1.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-5-8,143 0.1%   
Tax Rs m632-5,707 -11.1%   
Profit after tax Rs m1,301-113,448 -1.1%  
Gross profit margin %23.812.8 185.6%  
Effective tax rate %32.65.1 634.6%   
Net profit margin %19.2-12.5 -153.6%  
BALANCE SHEET DATA
Current assets Rs m6,984478,987 1.5%   
Current liabilities Rs m2,056349,322 0.6%   
Net working cap to sales %72.614.3 509.4%  
Current ratio x3.41.4 247.7%  
Inventory Days Days9958 171.1%  
Debtors Days Days2466 36.1%  
Net fixed assets Rs m244111,012 0.2%   
Share capital Rs m2270-   
"Free" reserves Rs m5,4410-   
Net worth Rs m5,6681,971,838 0.3%   
Long term debt Rs m251,033,282 0.0%   
Total assets Rs m7,9013,613,729 0.2%  
Interest coverage x353.3-2.9 -12,305.2%   
Debt to equity ratio x00.5 0.8%  
Sales to assets ratio x0.90.3 341.3%   
Return on assets %16.5-2.3 -704.6%  
Return on equity %22.9-5.8 -398.8%  
Return on capital %34.0-3.0 -1,130.7%  
Exports to sales %0.20-   
Imports to sales %36.30-   
Net fx Rs m-2,6620-   
CASH FLOW
From Operations Rs m923156,113 0.6%  
From Investments Rs m317-373,794 -0.1%  
From Financial Activity Rs m-481210,018 -0.2%  
Net Cashflow Rs m759-7,663 -9.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 69.6 Rs / USD

Compare WYETH LTD With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare WYETH LTD With: TTK HEALTHCARE  PFIZER  JUBILANT LIFE SCIENCES  SHASUN PHARMA  AJANTA PHARMA  



Today's Market

Sensex, Nifty Close at Record Highs; Healthcare and Power Stocks Witness Buying(Closing)

Indian share markets continued to trade on a flat during closing hours of trade and ended the day marginally higher to close at fresh record high levels.

Related Views On News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

Eris Lifesciences Limited (IPO)

Jun 15, 2017

Exposure to high margin specialty products offers promising growth prospects.

Laurus Labs Ltd (IPO)

Dec 6, 2016

Equitymaster analyses Initial Public Offering (IPO) of Laurus Labs, one of the leading supplier of APIs for ARVs and Hepatitis C.

More Views on News

Most Popular

This is a Must-Have Stock for Your Portfolio(The 5 Minute Wrapup)

Aug 8, 2018

Tanushree just released the permanent wealth blueprint report. This report includes three safe and steady stocks. I like one in particular. Here's why

Trading in These Times: 8% Gains in 3 Days!(Profit Hunter)

Aug 9, 2018

Here are 2 stocks you can buy right now! And there are plenty more opportunities to come...

Only on WhatsApp, a Weaker Rupee Means a Weaker India(Vivek Kaul's Diary)

Aug 16, 2018

While dollar crossing Rs 70 will have its repercussions, the world isn't exactly coming to an end.

Why HDFC Equity Fund Disappointed Its Investors(Outside View)

Aug 9, 2018

Though popular, HDFC Equity Fund is not among the best performers anymore. Here is the reason behind its underperformance that has left investors disappointed.

HDFC AMC Makes 65% Listing Gains! Should It Attract Mutual Fund Investors?(Outside View)

Aug 8, 2018

PersonalFN explains if investors should invest in schemes of HDFC Mutual Fund looking at the listing gains of HDFC AMC.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WYETH LTD - FULFORD INDIA COMPARISON

COMPARE WYETH LTD WITH

MARKET STATS